JP2018035153A5 - - Google Patents

Download PDF

Info

Publication number
JP2018035153A5
JP2018035153A5 JP2017163690A JP2017163690A JP2018035153A5 JP 2018035153 A5 JP2018035153 A5 JP 2018035153A5 JP 2017163690 A JP2017163690 A JP 2017163690A JP 2017163690 A JP2017163690 A JP 2017163690A JP 2018035153 A5 JP2018035153 A5 JP 2018035153A5
Authority
JP
Japan
Prior art keywords
genus
versus
graft
host disease
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017163690A
Other languages
English (en)
Japanese (ja)
Other versions
JP6408092B2 (ja
JP2018035153A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018035153A publication Critical patent/JP2018035153A/ja
Publication of JP2018035153A5 publication Critical patent/JP2018035153A5/ja
Application granted granted Critical
Publication of JP6408092B2 publication Critical patent/JP6408092B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017163690A 2016-08-29 2017-08-28 糞便微生物叢を含む組成物 Active JP6408092B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016166656 2016-08-29
JP2016166656 2016-08-29

Publications (3)

Publication Number Publication Date
JP2018035153A JP2018035153A (ja) 2018-03-08
JP2018035153A5 true JP2018035153A5 (enExample) 2018-05-17
JP6408092B2 JP6408092B2 (ja) 2018-10-17

Family

ID=61565352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017163690A Active JP6408092B2 (ja) 2016-08-29 2017-08-28 糞便微生物叢を含む組成物

Country Status (2)

Country Link
US (2) US20180185421A1 (enExample)
JP (1) JP6408092B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3062063B1 (fr) * 2017-01-26 2019-04-19 Centre National De La Recherche Scientifique Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
CA3099880A1 (en) * 2018-06-14 2019-12-19 4D Pharma Research Ltd Compositions comprising bacterial strains
MX2018010105A (es) * 2018-08-21 2020-02-24 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Sistema de estabilización de microbiota intestinal humana.
US12144834B2 (en) 2018-09-13 2024-11-19 Xbiome Inc. Methods and compositions for treating gastrointestinal and inflammatory disorders
US20220218800A1 (en) * 2019-05-06 2022-07-14 Synthetic Biologics, Inc. Beta-lactamase compositions for treatment of graft versus host disease
EP4085916A4 (en) * 2019-11-26 2024-03-27 Tokyo Metropolitan Hospital Organization PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR GRAFT VERSUS HOST DISEASE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
WO2005032589A1 (ja) * 2003-10-02 2005-04-14 Japan Science And Technology Agency Gvhdの予防及び治療
WO2011151941A1 (ja) * 2010-06-04 2011-12-08 国立大学法人東京大学 制御性t細胞の増殖または集積を誘導する作用を有する組成物
EP3569690B1 (en) * 2011-12-01 2024-08-28 The University of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
KR20150103012A (ko) * 2012-11-26 2015-09-09 토마스 줄리어스 보로디 분변 마이크로바이오타 복원을 위한 조성물 및 이의 제조 및 사용 방법
RU2015140610A (ru) * 2013-03-14 2017-04-17 ТЕРАБАЙОМ, ЭлЭлСи Направленная доставка в желудочно-кишечный тракт пробиотических микроорганизмов и/или терапевтических средств
WO2014145958A2 (en) * 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
US9795604B2 (en) * 2013-10-25 2017-10-24 Pharmacyclics Llc Methods of treating and preventing graft versus host disease
EP3066193B1 (en) * 2013-11-04 2024-07-10 Isopogen Pty Ltd Cell culture method
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
DK3223835T3 (en) * 2014-11-25 2025-02-17 Memorial Sloan Kettering Cancer Center Intestinal microbiota and gvhd

Similar Documents

Publication Publication Date Title
JP2018035153A5 (enExample)
JP2015527308A5 (enExample)
JP2014158488A5 (enExample)
JP2018039833A5 (enExample)
FI3146065T3 (fi) Menetelmiä ja koostumuksia clostridium difficile -infektion vähentämiseksi
JP2018100276A5 (enExample)
JP2015213501A5 (enExample)
JP2018012698A5 (enExample)
JP2019508486A5 (enExample)
JP2019526543A5 (enExample)
JP2016529309A5 (enExample)
CO6251326A2 (es) Un exopolisacarido
RU2016143195A (ru) Применение lactobacilius rhamnosus для стимулирования восстановления разнообразия кишечной микробиоты после дисбактериоза
MX383749B (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
JP2019104717A5 (enExample)
JP2017019841A5 (enExample)
JP2013523758A5 (enExample)
WO2016198170A8 (en) Vaccines against streptococcus pneumoniae serotype 5
JP2015521034A5 (enExample)
JP2020137724A5 (enExample)
JP2016508368A5 (enExample)
JP2018043949A5 (enExample)
JP2013032308A5 (enExample)
JP2020137723A5 (enExample)